Curvebeam AI Ltd
ASX:CVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1), the stock would be worth AU$0.08 (34% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.8 | AU$0.06 |
0%
|
| 3-Year Average | 1 | AU$0.08 |
+34%
|
| 5-Year Average | 1 | AU$0.08 |
+34%
|
| Industry Average | 3.1 | AU$0.25 |
+302%
|
| Country Average | 2.5 | AU$0.2 |
+224%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| US |
C
|
Curvebeam AI Ltd
ASX:CVB
|
26.5m AUD | 0.8 | -1.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.2B USD | 9.3 | 57.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161.2B USD | 3.1 | 25.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.8B USD | 5.5 | 37.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.4B USD | 2.1 | 22.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.9B USD | 3.6 | 24.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 4.6 | 43.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.8B EUR | 2.2 | 18.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 28.3 | 42.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.8B USD | 1.7 | 24 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.3B USD | 5 | 21.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.5 |
| 70th Percentile | 4.8 |
| Max | 147 580.5 |
Other Multiples
Curvebeam AI Ltd
Glance View
Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.
